Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R | Q15722 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | CASP6 | P55212 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.38 |
| ▸ | XDH | P47989 | 1/20 | 0.35 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.35 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.35 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9163981 | 1.00 | LTB4R (0.42) | LTB4RMEN1KMT2APOLBCASP6 | |
| SCHEMBL9162496 | 0.91 | MEN1 (0.47) | MEN1KMT2APOLBL3MBTL1CTDSP1 | |
| SCHEMBL9162488 | 0.91 | MEN1 (0.47) | MEN1KMT2APOLBL3MBTL1CTDSP1 | |
| SCHEMBL9164164 | 0.89 | NFE2L2 (0.44) | MEN1KMT2APOLB | |
| SCHEMBL9164174 | 0.89 | NFE2L2 (0.44) | MEN1KMT2APOLB | |
| SCHEMBL9166291 | 0.86 | MEN1 (0.50) | MEN1KMT2A | |
| SCHEMBL9166285 | 0.86 | MEN1 (0.50) | MEN1KMT2A | |
| SCHEMBL9157208 | 0.80 | MEN1 (0.49) | MEN1KMT2AL3MBTL1CTDSP1DUSP3 | |
| SCHEMBL9165474 | 0.77 | MAPT (0.38) | LTB4RMEN1KMT2APOLBL3MBTL1 | |
| SCHEMBL9161739 | 0.70 | STING1 (0.58) | MEN1KMT2ACTDSP1DUSP3PTPN5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5409952-A | Anticancer agents | ADIR ET COMPAGNIE (FR) | 1995-04-25 | — | — | US | disclosed |